Saturday, May 13, 2017 1:24:09 PM
http://news.cmlviz.com/2017/05/07/breaking-down-cellular-biomedicine-group-inc-nasdaq-cbmg--stock-drop-below-support--technicals-hit-extreme-weakness.html
https://www.equities.com/news/cellular-biomedicine-group-inc-cbmg-settles-into-new-52-week-low-on-may-11-session
I could not find any thing negative about the company itself that would cause such a massive decline. There is no bad news out there on management, trials, stock multiplication, or write ups from any stock analysis.
Usually this type of extreme drop is triggered by some type of substantial event, and I'll be darn I can't find any anywhere.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM